🇺🇸 FDA
Pipeline program

Immunoglobulins, Intravenous (Privigen)

OVG 2014/05

Phase 3 small_molecule completed

Quick answer

Immunoglobulins, Intravenous (Privigen) for Encephalitis is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Encephalitis
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials